Eli Lilly and Company has announced plans to invest more than $1 billion over the next few years to expand contract manufacturing operations in India.

The move is expected to benefit domestic contract manufacturing organisations (CMOs), suppliers, and technology partners, while strengthening India’s position as a global pharmaceutical hub. Advertisement

The investment will enhance manufacturing and supply capabilities for Lilly’s growing portfolio and improve access to its medicines worldwide.

A new Manufacturing and Quality hub in Hyderabad will oversee the company’s contract manufacturing network across India. Recruitment for engineers, chemists, analytical scientists, quality control and assurance professionals, and management roles is set to begin immediately.

Lilly already operat

See Full Page